

Learn which medications interact with Trelegy Ellipta, what to avoid, and what to tell your doctor before starting this triple-combination inhaler.
Trelegy Ellipta contains three active ingredients — fluticasone furoate, umeclidinium, and vilanterol — each of which can interact with other medications. Because it's a triple-combination inhaler, the list of potential interactions is broader than with single-ingredient inhalers.
Understanding these interactions is important because they can increase side effects, reduce Trelegy's effectiveness, or create new health risks. Always tell your doctor and pharmacist about every medication you take — including prescriptions, over-the-counter drugs, and supplements.
This is the most clinically significant drug interaction for Trelegy Ellipta. Both fluticasone furoate and vilanterol are metabolized (broken down) by an enzyme called CYP3A4 in the liver. Drugs that strongly inhibit this enzyme cause fluticasone and vilanterol to build up in your body, increasing the risk of side effects.
When these drugs are combined with Trelegy, elevated fluticasone levels can lead to:
Elevated vilanterol levels can cause:
If you need a strong CYP3A4 inhibitor, your doctor may monitor you more closely or consider alternative treatments. Do not stop either medication on your own — talk to your doctor about the best approach.
Beta-blockers are commonly prescribed for high blood pressure, heart failure, and irregular heartbeat. They can block the bronchodilatory effects of vilanterol (the LABA component), potentially making Trelegy less effective at keeping your airways open.
If you take a beta-blocker, make sure your prescribing doctor knows you're on Trelegy. A cardioselective beta-blocker may be substituted.
These psychiatric medications can potentiate (amplify) the cardiovascular effects of vilanterol:
When combined with Trelegy, these medications can increase the risk of rapid heart rate, blood pressure changes, and other cardiovascular side effects. Your doctor should weigh the benefits and risks carefully and may monitor your heart more closely.
Umeclidinium (the LAMA in Trelegy) is an anticholinergic drug. Taking additional anticholinergic medications can cause additive side effects:
Since Trelegy already contains vilanterol (a LABA), do not use other LABA-containing inhalers at the same time. Doubling up on LABAs increases the risk of cardiovascular side effects including rapid heart rate and low potassium. This includes:
Diuretics (water pills) like furosemide (Lasix), hydrochlorothiazide (HCTZ), and bumetanide can lower potassium levels. Since vilanterol can also lower potassium, using them together may increase the risk of hypokalemia (dangerously low potassium). Symptoms include:
If you take diuretics with Trelegy, your doctor may monitor your potassium levels periodically.
While every situation is different, many common medications can typically be used alongside Trelegy Ellipta without significant concern:
However, always confirm with your doctor or pharmacist, as individual factors matter.
Before starting Trelegy Ellipta, give your doctor a complete list of:
Also mention any history of heart disease, seizures, thyroid disorders, diabetes, liver disease, or eye conditions (glaucoma or cataracts), as these may affect how your doctor manages potential interactions.
Trelegy Ellipta is generally well-tolerated, but its three-ingredient formula means there are more potential drug interactions to be aware of. The most important ones involve strong CYP3A4 inhibitors, non-selective beta-blockers, other LABA or anticholinergic medications, and non-potassium-sparing diuretics. Always keep your healthcare team informed about every medication you take.
For more on using Trelegy safely, see our side effects guide. Need help finding Trelegy? Use MedFinder to locate pharmacies with it in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.